NURS 5433 MODULE 2 RESPIRATORY
COMPREHENSIVE STUDY SCRIPT VERIFIED
QUESTIONS ANSWERS ACCURATE
SOLUTIONS PACK
●● Low ICS
Answer: *Budesonide: 180-360 mcg/day (Pulmicort) and Fluticasone
propionate: 100-250 mcg/day (Flovent)
Beclomethasone: 80-160 mcg/day
Mometasone: 110 mcg/day
●● Medium ICS
Answer: • Budesonide: 361-720 mcg/day (Pulmicort )
• Fluticasone propionate: 251-500 mcg/day (Flovent )
• Beclomethasone: 161-320 mcg/day
• Mometasone: 220-440 mcg/day
●● High ICS
Answer: • Budesonide: >720 mcg/day (Pulmicort)
• Fluticasone propionate: >500 mcg/day (Flovent HFA)
• Beclomethasone: >320 mcg/day
,• Mometasone: >440 mcg/day
●● SABA
Answer: Short-acting beta agonists such as salbutamol (albuterol) and
terbutaline.
●● LAMA
Answer: Long-acting muscarinic antagonists like tiotropium and
beclomethasone-formoterol glycopyrronium.
●● LABA
Answer: Long-acting beta agonists such as salmeterol and formoterol.
●● ICS and LABA combo
Answer: Combination medications like beclomethasone/formoterol and
budesonide/formoterol.
●● SAMA
Answer: Short-acting muscarinic antagonists such as ipratropium
bromide and oxitropium bromide (combo with SABA).
●● Oral corticosteroids
Answer: Prednisone, prednisolone, and methylprednisolone.
, ●● Anti-IgE
Answer: Omalizumab, a medication used for asthma management.
●● Leukotriene modifiers (LTRA)
Answer: Medications such as montelukast, pranlukast, and zileuton.
●● Sustained step-up treatment
Answer: Increase treatment for at least 2-3 months if symptoms persist
despite controller treatment.
●● Common issues to consider before stepping up asthma tx
Answer: Incorrect inhaler technique, poor adherence, modifiable risk
(smoking)
●● Short-term step-up treatment
Answer: Temporary increase in treatment for 1-2 weeks during
exacerbations.
●● Day-to-day adjustment
Answer: Using as-needed low dose ICS-formoterol for mild asthma or
ICS-formoteral as a maintenance and reliever therapy.
COMPREHENSIVE STUDY SCRIPT VERIFIED
QUESTIONS ANSWERS ACCURATE
SOLUTIONS PACK
●● Low ICS
Answer: *Budesonide: 180-360 mcg/day (Pulmicort) and Fluticasone
propionate: 100-250 mcg/day (Flovent)
Beclomethasone: 80-160 mcg/day
Mometasone: 110 mcg/day
●● Medium ICS
Answer: • Budesonide: 361-720 mcg/day (Pulmicort )
• Fluticasone propionate: 251-500 mcg/day (Flovent )
• Beclomethasone: 161-320 mcg/day
• Mometasone: 220-440 mcg/day
●● High ICS
Answer: • Budesonide: >720 mcg/day (Pulmicort)
• Fluticasone propionate: >500 mcg/day (Flovent HFA)
• Beclomethasone: >320 mcg/day
,• Mometasone: >440 mcg/day
●● SABA
Answer: Short-acting beta agonists such as salbutamol (albuterol) and
terbutaline.
●● LAMA
Answer: Long-acting muscarinic antagonists like tiotropium and
beclomethasone-formoterol glycopyrronium.
●● LABA
Answer: Long-acting beta agonists such as salmeterol and formoterol.
●● ICS and LABA combo
Answer: Combination medications like beclomethasone/formoterol and
budesonide/formoterol.
●● SAMA
Answer: Short-acting muscarinic antagonists such as ipratropium
bromide and oxitropium bromide (combo with SABA).
●● Oral corticosteroids
Answer: Prednisone, prednisolone, and methylprednisolone.
, ●● Anti-IgE
Answer: Omalizumab, a medication used for asthma management.
●● Leukotriene modifiers (LTRA)
Answer: Medications such as montelukast, pranlukast, and zileuton.
●● Sustained step-up treatment
Answer: Increase treatment for at least 2-3 months if symptoms persist
despite controller treatment.
●● Common issues to consider before stepping up asthma tx
Answer: Incorrect inhaler technique, poor adherence, modifiable risk
(smoking)
●● Short-term step-up treatment
Answer: Temporary increase in treatment for 1-2 weeks during
exacerbations.
●● Day-to-day adjustment
Answer: Using as-needed low dose ICS-formoterol for mild asthma or
ICS-formoteral as a maintenance and reliever therapy.
